Back
Merck & Vs. Dave Industry Stock Comparison
Sell
23
MRK
Merck &
Last Price:
$92.22
Seasonality Move:
3.26%
Buy
64
DAVE
Dave
Last Price:
$100.69
Seasonality Move:
-2.23%
Sell
23
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
-
MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRK Stock Price Chart
DAVE Stock Price Chart
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.65 | Sell |
Relative Strength Index (14 RSI): | 52.95 | Buy |
Chaikin Money Flow: | 13240252 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (85.69 - 96.31) | Buy |
Bollinger Bands (100): | (92.82 - 105.94) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.23 | Buy |
Relative Strength Index (14 RSI): | 49.59 | Sell |
Chaikin Money Flow: | 296231 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (93.94 - 109.78) | Sell |
Bollinger Bands (100): | (54.87 - 102.95) | Buy |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 88.71 | Buy |
20-day SMA: | 89.45 | Buy |
50-day SMA: | 95.17 | Sell |
200-day SMA: | 110.95 | Sell |
8-day EMA: | 89.59 | Buy |
20-day EMA: | 90.19 | Buy |
50-day EMA: | 94.14 | Sell |
200-day EMA: | 105.78 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 104.99 | Sell |
20-day SMA: | 104.31 | Sell |
50-day SMA: | 96.22 | Buy |
200-day SMA: | 58.36 | Buy |
8-day EMA: | 103 | Sell |
20-day EMA: | 102.6 | Sell |
50-day EMA: | 95.16 | Buy |
200-day EMA: | 65.4 | Buy |
Merck & Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.11 per share, an increase this year of $1.37 per share, and an increase next year of $0.95 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.73 per share, and an increase next year of $1.09 per share.
Merck & Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | Feb 25 | Feb 26 | Feb 27 | Feb 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
13 | 14 | 18 | 19 | 20 | 21 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |